Cagrilintide Research Compound (CGL)

"Premium grade Cagrilintide validation."

Cagrilintide is a lipidated, long-acting analog of the pancreatic hormone amylin, engineered for reversible albumin binding to support once-weekly administration. It is studied in metabolic pathway research as an amylin receptor agonist whose in vivo activity depends on the AMY1 and AMY3 receptor subtypes (Kruse et al., J Med Chem 2021, PMID 34288673). Cagrilintide research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.